ABO and Alzheimer disease: Hence, AβO immunogens have been constructed with the Aβ1-15 region deleted, to prevent adverse antibody responses [27]; paradoxically, these undesirable immunoresponses are the ones being induced by practically all of the AD vaccines clinically tested or under development (Table 1).